Literature DB >> 1506861

Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome.

E Sforza1, J Krieger.   

Abstract

A modified maintenance of wakefulness test was performed in 58 patients with obstructive sleep apnea (OSA) syndrome before treatment and after long-term (554 +/- 28 days) home therapy with nasal continuous positive airway pressure (CPAP). Before treatment the patients had a shorter mean sleep latency than controls (16 +/- 1 vs. 27 +/- 1 min, mean +/- SEM, P less than 0.001). After treatment, the mean sleep latency increased to 20 +/- 1 min (P less than 0.002 as compared to baseline), but was still shorter than in controls (P less than 0.001). The incomplete normalization of the mean latency contrasted with the patients' claim that they no longer felt sleepy. The improvement in daytime alertness was significantly correlated with the reduction in sleep fragmentation after CPAP treatment and with the baseline mean sleep latency. These results support the hypothesis that sleep disruption related to respiratory events plays a role in the pathogenesis of daytime sleepiness.

Entities:  

Mesh:

Year:  1992        PMID: 1506861     DOI: 10.1016/0022-510x(92)90004-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

Review 1.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

2.  Respiratory cycle-related EEG changes: response to CPAP.

Authors:  Ronald D Chervin; Anita Valanju Shelgikar; Joseph W Burns
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

Review 3.  Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults.

Authors:  John M Dopp; Barbara J Morgan
Journal:  Sleep Breath       Date:  2010-06-28       Impact factor: 2.816

4.  Self-efficacy contributes to individual differences in subjective improvements using CPAP.

Authors:  Kelly Glazer Baron; Cynthia A Berg; Laura A Czajkowski; Timothy W Smith; Heather E Gunn; Christopher R Jones
Journal:  Sleep Breath       Date:  2010-09-16       Impact factor: 2.816

5.  Evaluation of the safety of modafinil for treatment of excessive sleepiness.

Authors:  Thomas Roth; Jonathan R L Schwartz; Max Hirshkowitz; Milton K Erman; Jeffrey M Dayno; Sanjay Arora
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

6.  Recognition and management of excessive sleepiness in the primary care setting.

Authors:  Jonathan R L Schwartz; Thomas Roth; Max Hirshkowitz; Kenneth P Wright
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

7.  Maintenance of wakefulness test in military personnel with upper airway resistance syndrome and mild to moderate obstructive sleep apnea.

Authors:  Christopher R Powers; William C Frey
Journal:  Sleep Breath       Date:  2009-02-20       Impact factor: 2.816

8.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

9.  Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.

Authors:  Max Hirshkowitz; Jed Black
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Modafinil in the treatment of excessive sleepiness.

Authors:  Jonathan R L Schwartz
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.